Curative Biotechnology, Inc. (CUBT)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 97.51 Thousand | 7956.00 | 6744.00 | 5301.00 | 5301.00 | 5301.00 |
| Gross Profit | -97.51 Thousand | -7956.00 | -6744.00 | -5301.00 | -5301.00 | -5301.00 |
| Operating Expenses | 1.83 Million | 4.43 Million | 4.99 Million | 4.6 Million | 5451.00 | 5451.00 |
| Selling, General and Administrative Expenses | 1.56 Million | 1.94 Million | 4.21 Million | 4.59 Million | 150.00 | 150.00 |
| Research and Development Expenses | 269.78 Thousand | 2.48 Million | 779.27 Thousand | - | - | - |
| Other Expenses | - | 4914.00 | - | - | - | - |
| Cost and Expenses | 1.93 Million | 4.43 Million | 4.99 Million | 4.6 Million | 5451.00 | 5451.00 |
| Operating Income | -1.93 Million | -4.43 Million | -5.01 Million | -4.63 Million | -5451.00 | -5451.00 |
| Interest Expense | 1.35 Million | 1.17 Million | 176.67 Thousand | 34.51 Thousand | 15.88 Thousand | 15.88 Thousand |
| Income Tax Expense | - | 1.17 Million | 176.67 Thousand | 34.51 Thousand | 15.88 Thousand | 15.88 Thousand |
| Earnings before Tax | -3.95 Million | -5.6 Million | -5.34 Million | -4.67 Million | 331.95 Thousand | -29.91 Thousand |
| Net Income | -5.81 Million | -5.6 Million | -5.34 Million | -4.67 Million | 331.95 Thousand | -29.91 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.00 |
| Weighted Average Shares Outstanding | 662.16 Million | 572 Million | 500.98 Million | 326.67 Million | 322.8 Million | 322.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 662.16 Million | 572 Million | 500.98 Million | 326.67 Million | 322.8 Million | 322.8 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.5 Million | -4.36 Million | -5.15 Million | -4.59 Million | -150.00 | -8731.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 21.92 Thousand | 26.42 Thousand | 97.51 Thousand | 91.54 Thousand | 1989.00 | 1989.00 |
| Gross Profit | -21.92 Thousand | -26.42 Thousand | -97.51 Thousand | -91.54 Thousand | -1989.00 | -1989.00 |
| Operating Expenses | 549.28 Thousand | 681.39 Thousand | 1.83 Million | 455.8 Thousand | 665.18 Thousand | 61.24 Thousand |
| Selling, General and Administrative Expenses | 545.51 Thousand | 675.74 Thousand | - | 446.06 Thousand | 646.49 Thousand | 60.74 Thousand |
| Research and Development Expenses | 3775.00 | 5652.00 | - | 9739.00 | 18.69 Thousand | 501.00 |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 571.21 Thousand | 707.82 Thousand | 1.93 Million | 547.35 Thousand | 667.17 Thousand | 63.23 Thousand |
| Operating Income | -571.22 Thousand | -707.82 Thousand | -1.93 Million | -547.36 Thousand | -667.18 Thousand | -63.24 Thousand |
| Interest Expense | 127.03 Thousand | 191.59 Thousand | 1.35 Million | 824.65 Thousand | 152.95 Thousand | 68.73 Thousand |
| Income Tax Expense | 2.00 | 1.00 | -5.00 | 2.00 | 1.00 | 1.00 |
| Earnings before Tax | -697.74 Thousand | -899.34 Thousand | -3.95 Million | -2.03 Million | -820.12 Thousand | -131.97 Thousand |
| Net Income | -697.74 Thousand | -899.34 Thousand | -3.95 Million | -2.03 Million | -820.12 Thousand | -131.97 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 903.26 Million | 903.26 Million | 662.16 Million | 903.26 Million | 628.92 Million | 604.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 903.26 Million | 903.26 Million | 662.16 Million | 903.26 Million | 628.92 Million | 604.5 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -549.29 Thousand | -681.39 Thousand | - | -455.81 Thousand | -665.19 Thousand | -61.25 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
BEL
DEVYANI
4019
PBI
HL
SHB-B